These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3433251)

  • 1. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding.
    Tripodi A; Krachmalnicoff A; Mannucci PM
    Thromb Haemost; 1986 Dec; 56(3):349-52. PubMed ID: 3563966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.
    Wolf M; Boyer C; Tripodi A; Meyer D; Larrieu MJ; Mannucci PM
    Blood; 1985 Feb; 65(2):496-500. PubMed ID: 3967090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K; Ueyama H; Hashimoto Y; Sasaki Y; Matsumoto K; Okabe H; Inoue M; Araki S; Takatsuki K
    Thromb Haemost; 1989 Feb; 61(1):20-4. PubMed ID: 2749590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
    Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
    Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA; Reber G; Vernet P; Minazio P; Bouvier CA
    Thromb Haemost; 1987 Apr; 57(2):154-7. PubMed ID: 3603409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").
    Sambrano JE; Jacobson LJ; Reeve EB; Manco-Johnson MJ; Hathaway WE
    J Clin Invest; 1986 Mar; 77(3):887-93. PubMed ID: 3512602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin-III-Hamilton, Ala 382 to Thr: an antithrombin-III variant that acts as a substrate but not an inhibitor of alpha-thrombin and factor Xa.
    Austin RC; Rachubinski RA; Ofosu FA; Blajchman MA
    Blood; 1991 May; 77(10):2185-9. PubMed ID: 2029579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and functional study of antithrombin III in newborn infants.
    McDonald MM; Hathaway WE; Reeve EB; Leonard BD
    Thromb Haemost; 1982 Feb; 47(1):56-8. PubMed ID: 7071806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys.
    Erdjument H; Lane DA; Ireland H; Di Marzo V; Panico M; Morris HR; Tripodi A; Mannucci PM
    Thromb Haemost; 1988 Dec; 60(3):471-5. PubMed ID: 3238650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of immobilized thrombin with human antithrombin III.
    Marciniak E; Gora-Maslak G
    Thromb Haemost; 1984 Feb; 51(1):27-31. PubMed ID: 6719385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities.
    De Stefano V; Leone G; Mastrangelo S; Lane DA; Girolami A; de Moerloose P; Sas G; Abildgaard U; Blajchman M; Rodeghiero F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):7-15. PubMed ID: 8180341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.